Status: open
Lovenox® (Enoxaparin)
Defendant: Momenta; Sandoz
Consumers who bought certain dosages of Lovenox® and/or its generic version Enoxaparin between September 21, 2011 and September 30, 2015 may be eligible for payment. The companies reached a settlement over allegations of antitrust violations.